Get in Touch
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Access to patient data from all over the world
Electronic Health Records
Germany, The United Kingdom, Spain, Portugal, The Netherlands, Switxerland, Czechia, Slovakia, Belorus, Russia, Canada, USA, Turkey, United Arab Emirates, Israel, Saudi Arabia
Harnessing and transforming RWD into RWE
Real-World Evidence for complex healthcare decision making
Combining data, AI-technology,
and analytics to empower your trials
Collection, processing, and harmonization of unstructured data using algorithms, which are quickly adapted for a particular task. We provide curated datasets to answer your research questions.
Deep Learning techniques for the extraction of medical information including entity recognition and relation extraction. We deliver AI-powered algorithms for evidence representation.
End-to-end solutions including study design, feasibility, patient recruitment and final reports.
Deployment of customized web tools for healthcare professionals, patients, and sponsors.
Continuously growing network
EHR data form 700+ research sites and data partners around the globe
Solutions for your specific clinical trial needs
Global data for your clinical study
DM RWE collects and processes Real-World Data and delivers it to healthcare stakeholders from all over the world. We source proprietary datasets from electronic health records (EHRs), patient reported outcomes (PROs) and clinical trial reports from public databases (ClinicalTrials.gov), and scientific articles (PubMed, Google Scholar, ScienceDirect).
Innovative solutions for traditional clinical research
DM RWE offers a wide range of clinical trial services for you to reach your research objectives. Our well-balanced team of biostatisticians, clinical trials experts and data scientists ensure delivery of a synopsis, study protocol, and comprehensive study design for your trial.
Boosted awareness among healthcare professionals
DM RWE develops UI/UX friendly and easy-to-use web tools to facilitate interaction between physicians and patients, and ultimately to raise their awareness of innovative therapies. Our Treatment Analyzing solutions enable healthcare professionals to apply study findings for more informed decisions on diagnosis and the best available therapies for each patient.
1 000 000+
electronic health records
Real World Evidence Solutions for your Study
"Smart" patient registry
Marketing analysis of prescriptions
Drug treatment efficacy and safety
Post-authorization and additional studies
Development of a full document set for trial
Clinical study design
Clinical study protocol
Clinical study reports
Articles and publications
Translation of documents
Scientific approach to study planning and data analysis
Sample size calculation
Development of the statistical section of study protocol
Statistical analysis planning
Randomization schedule development
Statistical data analysis
Presentation of results in TFLs with explanatory notes
Development of interim and final statistical report
Set up of PVG specific processes and procedures
Collection, description and processing of serious adverse events data
Evaluation of safety data
Data entry and MedDRA coding
Medical review, quality control
Reporting to regulatory authorities and investigator sites about presumed serious and unforeseen adverse reactions (SUSAR)
Preparation and submission of annual safety reports to regulatory authorities and investigator sites
Modeling patient and healthcare system expenses on diagnostics and treatment
Determining RWD for modeling
Treatment analyzing tools
AI empowered predictive analytics tools for estimating patient survival based on Real-World Evidence extracted from Publications, Registries and Electronic health records.
The tool allows the estimation of the survival of a patient based on their individual parameters and performed or planned treatment, before being compared with the best treatment option for similar baseline data. DM RWE creates Treatment Analyzing tools for any therapeutic area with complex and expensive treatment regimens Talk to an expert
Estimate the capacity of RWD for your study with our online assistant, which delivers instant feasibility assessment based on the analysis of millions of electronic health records.
An intuitive user-friendly interface performs real-time analysis and enables preliminary estimation of whether presented datasets will fit your study goals. This will allow you to make an informed decision before making a purchase. Reach out to one of our experts and find out how the Feasibility Tool brings together all the variables of compliant use to generate the evidence you are looking for. Talk to an expert
Data Source Validation Tool
We are committed to providing research-ready high quality data.
Our quality control system is designed in a way that requires all data to be checked for accuracy and suitability at every level of processing. To that end we employ our special in-house designed automated Data Validation Tool. You can order data validation by our team as a standalone service or deploy it on your own by acquiring it as a SaaS solution. Talk to an expert
Discover the potential of the global RWD derived from millions of electronic health records. With our broad network of healthcare organizations from EU, CIS, MENA and APAC countries, we collect large datasets in a avariety of therapeutic areas. We deliver clinically enhanced data for oncology and oncohematology, which combines histology, genomic data, biomarkers, treatment, line change, and survival records. Using Artificial Intelligence, DM RWE mines valuable datasets and provides clean and curated data to answer your research questions
Talk to an expert
What clients say about DM RWE
Germany based biotech company
We’ve started working with DM RWE back in 2020. We’ve been more than happy with their delivery and performance. The team is very responsive, ethical and commited.
Head of Evidence Generation Projects
Pharmaceutical Company, Netherlands
We’ve been thoroughly impressed with the expanse of global patient data DM RWE has access to. But what’s important is that they work by the book and deliver utmost compliance and efficiency.